Merger of drugmakers Valeant, Actavis on hold: source

Sat Apr 27, 2013 4:19pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

(Reuters) - Talks are on hold to merge drugmakers Valeant Pharmaceuticals International Inc and Actavis Inc in a deal that would have created a healthcare giant, a person familiar with the situation told Reuters on Saturday.

A Valeant spokeswoman and an Actavis spokesman could not be immediately reached for comment outside of business hours.

(Reporting by Soyoung Kim in New York; writing by Rod Nickel in Winnipeg, Manitoba)